Literature DB >> 9464490

Integrated and episomal forms of Epstein-Barr virus (EBV) in EBV associated disease.

K Ohshima1, J Suzumiya, M Kanda, A Kato, M Kikuchi.   

Abstract

Epstein-Barr virus (EBV) is known to be linear in viral particles but EBV circularizes into an episomal form after infection. Recently, the presence of integrated EBV DNA has been reported. We investigated EBV integration into the human genome in EBV-associated disease using Southern blotting. One hundred four cases in which the presence of EBV was confirmed by Southern blotting with EBV-W probes were thus analyzed with left- and right-hand end probes of linear EBV. Integrated EBV was demonstrated in 11 of 104 cases; five of 14 cases with B cell lymphoma (36%), one of 12 cases with nasopharyngeal carcinomas (8%), four of 31 cases with natural killer (NK) leukemia/lymphoma (13%) and one of 11 cases with chronic EBV infection (9%). However, none of the 24 T cell lymphoma, seven Hodgkin's disease, or five acute EBV infection cases showed integrated EBV. In addition, seven of the 11 cases with EBV integration (five B cell lymphoma and two NK leukemia/lymphoma) showed only an integration form, however, the other four (two NK leukemia/lymphoma, one nasopharyngeal carcinoma and one chronic EBV infection) showed both integrated and episomal forms. The integrated form was frequently found in B cell lymphoma and especially in high grade B cell lymphoma. Fluorescence in situ hybridization (FISH) was performed in two cases (NK and B cell lymphoma), which represented integrated EBV in Southern blotting and the integration form was confirmed in both. However, it is still uncertain as to whether or not the EBV integration site is directly associated with chromosomal abnormality.

Entities:  

Mesh:

Year:  1998        PMID: 9464490     DOI: 10.1016/s0304-3835(97)00368-6

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  15 in total

1.  Real-time Epstein-Barr virus PCR for the diagnosis of primary EBV infections and EBV reactivation.

Authors:  Rianne Luderer; Marieke Kok; Hubert G M Niesters; Rob Schuurman; Okke de Weerdt; Steven F T Thijsen
Journal:  Mol Diagn       Date:  2005

Review 2.  The legacy of the F344 rat as a cancer bioassay model (a retrospective summary of three common F344 rat neoplasms).

Authors:  Robert R Maronpot; Abraham Nyska; Jennifer E Foreman; Yuval Ramot
Journal:  Crit Rev Toxicol       Date:  2016-06-09       Impact factor: 5.635

Review 3.  Post Transplant Lymphoproliferative Disorder.

Authors:  Devika Gupta; Satish Mendonca; Sushmita Chakraborty; Tathagata Chatterjee
Journal:  Indian J Hematol Blood Transfus       Date:  2019-09-17       Impact factor: 0.900

4.  Integrated Pan-Cancer Map of EBV-Associated Neoplasms Reveals Functional Host-Virus Interactions.

Authors:  Srishti Chakravorty; Bingyu Yan; Chong Wang; Luopin Wang; Joseph Taylor Quaid; Chin Fang Lin; Scott D Briggs; Joydeb Majumder; D Alejandro Canaria; Daniel Chauss; Gaurav Chopra; Matthew R Olson; Bo Zhao; Behdad Afzali; Majid Kazemian
Journal:  Cancer Res       Date:  2019-09-03       Impact factor: 12.701

5.  Rabbit model for human EBV-associated hemophagocytic syndrome (HPS): sequential autopsy analysis and characterization of IL-2-dependent cell lines established from herpesvirus papio-induced fatal rabbit lymphoproliferative diseases with HPS.

Authors:  Kazuhiko Hayashi; Zaishun Jin; Sachiyo Onoda; Hiromasa Joko; Norihiro Teramoto; Nobuya Ohara; Wakako Oda; Takehiro Tanaka; Yi-Xuan Liu; Tirtha Raj Koirala; Takashi Oka; Eisaku Kondo; Tadashi Yoshino; Kiyoshi Takahashi; Tadaatsu Akagi
Journal:  Am J Pathol       Date:  2003-05       Impact factor: 4.307

6.  Genomic Landscapes of Epstein-Barr Virus in Pulmonary Lymphoepithelioma-Like Carcinoma.

Authors:  Yan-Xia Wu; Wen-Li Zhang; Tong-Min Wang; Ying Liao; Yi-Jun Zhang; Ruo-Wen Xiao; Yi-Jing Jia; Zi-Yi Wu; Chang-Mi Deng; Da-Wei Yang; Wen-Qiong Xue; Yong-Qiao He; Xiao-Hui Zheng; Xi-Zhao Li; Ting Zhou; Pei-Fen Zhang; Shao-Dan Zhang; Ye-Zhu Hu; Jiang-Bo Zhang; Wei-Hua Jia
Journal:  J Virol       Date:  2021-12-15       Impact factor: 6.549

7.  Complex genomic rearrangement of ALK loci associated with integrated human Epstein-Barr virus in a post-transplant myogenic liver tumor.

Authors:  Maria Debiec-Rychter; Romaric Croes; Rita De Vos; Peter Marynen; Tania Roskams; Anne Hagemeijer; Rita Lombaerts; Raf Sciot
Journal:  Am J Pathol       Date:  2003-09       Impact factor: 4.307

8.  A probable identical Epstein-Barr virus clone-positive composite lymphoma with aggressive natural killer-cell leukemia and cytotoxic T-cell lymphoma.

Authors:  Kei-Ji Sugimoto; Asami Shimada; Mutsumi Wakabayashi; Hidenori Imai; Yasunobu Sekiguchi; Noriko Nakamura; Tomohiro Sawada; Yasunori Ota; Kengo Takeuchi; Yoshinori Ito; Hiroshi Kimura; Norio Komatsu; Masaaki Noguchi
Journal:  Int J Clin Exp Pathol       Date:  2013-12-15

9.  In depth comparison of an individual's DNA and its lymphoblastoid cell line using whole genome sequencing.

Authors:  Dorothee Nickles; Lohith Madireddy; Shan Yang; Pouya Khankhanian; Steve Lincoln; Stephen L Hauser; Jorge R Oksenberg; Sergio E Baranzini
Journal:  BMC Genomics       Date:  2012-09-14       Impact factor: 3.969

10.  Genome-wide profiling of Epstein-Barr virus integration by targeted sequencing in Epstein-Barr virus associated malignancies.

Authors:  Miao Xu; Wei-Long Zhang; Qing Zhu; Shanshan Zhang; You-Yuan Yao; Tong Xiang; Qi-Sheng Feng; Zhe Zhang; Rou-Jun Peng; Wei-Hua Jia; Gui-Ping He; Lin Feng; Zhao-Lei Zeng; Bing Luo; Rui-Hua Xu; Mu-Sheng Zeng; Wei-Li Zhao; Sai-Juan Chen; Yi-Xin Zeng; Yuchen Jiao
Journal:  Theranostics       Date:  2019-01-30       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.